» Articles » PMID: 14688249

S Phase-specific Transcription of the Mouse Ribonucleotide Reductase R2 Gene Requires Both a Proximal Repressive E2F-binding Site and an Upstream Promoter Activating Region

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Dec 23
PMID 14688249
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Ribonucleotide reductase is essential for supplying a balanced pool of the four deoxyribonucleotides required for DNA synthesis and repair. The active enzyme consists of two non-identical subunits called proteins R1 and R2. There are multiple levels of regulation of ribonucleotide reductase activity, which is highest during the S and G(2) phases of an unperturbed cell cycle in mammalian cells. Previous reports in the literature have indicated that the S phase-specific transcription of the mammalian R2 gene is regulated by a transcriptional block, is dependent on the transcription factor E2F1, or is simply regulated by proteins that bind to promoter CCAAT boxes plus the TATA box. Here, we demonstrate that the S phase-specific transcription of the mouse R2 gene is dependent on an upstream promoter activating region (located at nucleotides (nt) -672 to -527 from the transcription start site) and one proximal promoter repressive element (located at nt -112 to -107) that binds E2F4. Binding to the E2F site is modulated by binding of nuclear factor-Y to an adjacent CCAAT element (nt -79 to -75). The upstream activating region is crucial for overall R2 promoter activity. Mutation of the E2F-binding site leads to premature promoter activation in G(1) and increases overall promoter activity but only when the upstream activating region is present and intact. Therefore, E2F-dependent repression is essential for cell cycle-specific R2 transcription.

Citing Articles

E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network.

Poliakova Turan M, Riedo R, Medo M, Pozzato C, Friese-Hamim M, Koch J Cancer Res Commun. 2024; 4(7):1863-1880.

PMID: 38957115 PMC: 11288008. DOI: 10.1158/2767-9764.CRC-23-0370.


A structure-based designed small molecule depletes hRpn13 and a select group of KEN box proteins.

Lu X, Chandravanshi M, Sabbasani V, Gaikwad S, Hughitt V, Gyabaah-Kessie N Nat Commun. 2024; 15(1):2485.

PMID: 38509117 PMC: 10954691. DOI: 10.1038/s41467-024-46644-7.


Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor.

Giang L, Wu K, Lee W, Chu S, Do A, Changou C J Exp Clin Cancer Res. 2023; 42(1):346.

PMID: 38124207 PMC: 10731702. DOI: 10.1186/s13046-023-02911-x.


Molecular Insight into Iron Homeostasis of Acute Myeloid Leukemia Blasts.

Pourcelot E, El Samra G, Mossuz P, Moulis J Int J Mol Sci. 2023; 24(18).

PMID: 37762610 PMC: 10531764. DOI: 10.3390/ijms241814307.


Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.

Croushore E, Koppenhafer S, Goss K, Geary E, Gordon D Cancer Res Commun. 2023; 3(8):1580-1593.

PMID: 37599787 PMC: 10434289. DOI: 10.1158/2767-9764.CRC-23-0268.